Anaplasmosis Vaccine in Cattle

Anaplasmosis Vaccine in Cattle: What Producers Should Know

By Dr Duncan Houston

Anaplasmosis is one of the most frustrating and costly diseases in cattle. It can sit quietly in a herd, then suddenly cause severe illness, abortions, or deaths with very little warning. For years, control has relied on management and antibiotics, but vaccine development is now moving forward in a meaningful way.

The key question is not just whether a vaccine is coming. It is what that means for your herd right now and how you should be preparing.

This update follows your clinical article framework and the source content provided.

Quick Answer

An effective vaccine for anaplasmosis in cattle is not yet widely available, but promising candidates are in development, including live-attenuated, implant-based, and subunit vaccines. Until approval and rollout occur, control still depends on tick management, biosecurity, and early detection. Preparing your herd now will make vaccine integration far more effective when it becomes available.

What Is Anaplasmosis?

Anaplasmosis is caused by Anaplasma marginale, a bacteria that infects red blood cells.

What it does:
• Destroys red blood cells
• Causes anemia
• Reduces oxygen delivery

This leads to:
• Weakness
• Weight loss
• Reduced production
• Abortions
• Death in severe cases

Clinical insight:

The severity depends heavily on age. Older cattle tend to have more severe disease, while younger animals may show milder signs or become carriers.

How Does It Spread?

Transmission is a major challenge.

Common routes:

• Ticks
• Biting flies
• Contaminated needles or equipment

One of the biggest issues:
Carrier animals remain infected for life and silently spread the disease.

Decision checkpoint:

If you have had one confirmed case, assume the organism is already present in your herd.

Why Has a Vaccine Been So Difficult?

There is a reason we have been waiting decades.

Key challenges:
• Strain variation
• Immune evasion by the organism
• Difficulty creating long-lasting protection
• Safety concerns with live vaccines

This is not a simple pathogen. It changes how the immune system sees it, making consistent vaccine protection difficult.

What Vaccine Options Are Being Developed?

1. Live-attenuated vaccines

These are currently the most promising.

What they do:
• Use a weakened form of the organism
• Trigger a protective immune response without causing disease

Recent work has shown:
• Strong protection against challenge
• Better performance than killed vaccines

Clinical insight:

This is the first genuinely promising progress in decades, but safety and regulatory approval are still critical hurdles.

2. Implant-based delivery systems

A newer concept.

What they aim to do:
• Deliver antigen slowly over time
• Provide longer-lasting immunity
• Reduce the need for repeated injections

If successful, this could significantly improve compliance in large herds.

3. Subunit vaccines

These use specific proteins from the organism rather than the whole bacteria.

Advantages:
• Safer
• More targeted

Limitations:
• Often weaker immune response
• May require boosters

4. Killed (inactivated) vaccines

These already exist in some forms but:

• Often provide inconsistent protection
• May not prevent clinical disease effectively

In practice, these have not been reliable enough for broad success.

Severity Framework: What Anaplasmosis Looks Like in the Field

Mild

• Subtle drop in performance
• Mild anemia

Action:
Monitor and confirm diagnosis.

Moderate

• Weight loss
• Reduced appetite
• Pale mucous membranes

Action:
Veterinary involvement needed.

Severe

• Weakness
• Jaundice
• Abortions

Action:
Urgent treatment required.

Critical

• Collapse
• Death

Action:
Immediate intervention, though prognosis is poor in advanced cases.

When Is This an Emergency?

Treat as urgent if you see:

• Rapid onset weakness
• Pale or yellow mucous membranes
• Sudden drop in production
• Multiple animals affected

This disease can progress quickly, especially in adult cattle.

What Should You Do Right Now?

Until vaccines are available, focus on control:

1. Vector control

• Tick management
• Fly control
• Pasture rotation

2. Biosecurity

• Avoid sharing needles
• Disinfect equipment
• Manage new introductions carefully

3. Identify and manage carriers

• Test where appropriate
• Separate or manage risk animals

4. Strategic antibiotic use

• Early intervention may help
• Avoid overuse and resistance risk

Time-based guidance:

• Early detection improves outcomes
• Delayed treatment significantly worsens prognosis

Common Mistakes

• Assuming one recovered animal is no longer a risk
• Ignoring vector control
• Over-relying on antibiotics
• Not testing or monitoring herd status
• Waiting for obvious signs before acting

The biggest mistake is treating anaplasmosis as an individual animal problem instead of a herd-level disease.

What Should You Be Doing Before a Vaccine Arrives?

This is where smart producers gain an advantage.

Prepare now:

• Strengthen vector control programs
• Improve biosecurity protocols
• Track herd health data
• Work with your vet on future vaccination planning

Decision checkpoint:

If your system is not controlled now, a vaccine alone will not fix it later.

What Will Change When a Vaccine Becomes Available?

A vaccine will likely:

• Reduce disease severity
• Reduce economic losses
• Improve herd stability

But it will not eliminate the need for:
• Tick control
• Biosecurity
• Monitoring

Vaccines are a tool, not a replacement for management.

FAQ

Is there a vaccine available now?

Not widely approved or commercially available yet, but promising candidates are in development.

Will a vaccine eliminate anaplasmosis?

No. It will reduce risk and severity but not replace management practices.

Can cattle recover from anaplasmosis?

Some do, but they often remain carriers and can spread the disease.

How fast does the disease progress?

Severe cases can deteriorate rapidly, especially in adult cattle.

Should I change my management now?

Yes. Improving control now will make future vaccination far more effective.

Final Thoughts

Anaplasmosis is not new, but vaccine development is finally moving forward in a meaningful way.

The opportunity is not just in the vaccine itself.
It is in how prepared your system is to use it effectively.

The herds that benefit most will be the ones that already:
• Control vectors
• Manage biosecurity
• Monitor herd health closely

If you want help assessing your herd’s anaplasmosis risk, building a control plan, or preparing for future vaccine integration, ASK A VET™ can help you make practical, herd-level decisions with clarity and confidence.